Company / Free Cash Flow per Share
PROCEPT BioRobotics Corp Free Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.07
FY2025
5-year range
-$10.31 / -$1.07
FY2021-FY2025
Trend
+47.8%
vs FY2024
Sector context
#135 of 148
Health Care
What the data says
Among 148 Health Care companies, PROCEPT BioRobotics Corp is in the bottom 9% for free cash flow per share. Free Cash Flow per Share has increased for 5 consecutive years, from $-13.26 in FY2020 to $-1.07 in FY2025.
Based on SEC 10-K filings.
-1.07 in FY2025.
Improved from $-2.62 to $-1.07 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 148This company -$1.07 Sector average $5.04
▼
-121.1% below sector average
Key checks
Key Insights
- PROCEPT BioRobotics Corp's free cash flow per share has grown for 5 consecutive years.
- In FY2025, free cash flow per share increased 47.8% year-over-year.
- Ranks #135 out of 148 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.07 | +47.8% |
| FY2024 | -$2.04 | +22.2% |
| FY2023 | -$2.62 | +25.4% |
| FY2022 | -$3.51 | +65.9% |
| FY2021 | -$10.31 | +22.3% |
| FY2020 | -$13.26 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026